Shoaf, Susan E.
https://orcid.org/0000-0001-7725-9385
Mayo Clinic
Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)
Citations 1
Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial
Shoaf, Susan E. , Chapman, Arlene B., Torres, Vicente E. , Ouyang, John , Czerwiec, Frank S., Torres, Vicente E
The Journal of Clinical Pharmacology | February 20, 2017 | Volume: 57 | Issue: 7 | Pages: 906-917
